Recombinant Xenopus tropicalis Transcription factor Sox-10 (sox10)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchasing method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us.
Synonyms
sox10; Transcription factor Sox-10; SRY; sex determining region Y)-box 10
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-436
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)
Target Names
sox10
Target Protein Sequence
MSDDQSLSEV EMSPVGSEDP SLTPDPLPPH AHSSPDDDEE TKVKKEQDSE DERFPVCIRE AVSQVLSGYD WTLVPMPVRV NGGSKSKPHV KRPMNAFMVW AQAARRKLAD QYPHLHNAEL SKTLGKLWRL LNENDKRPFI EEAERLRMQH KKDHPDYKYQ PRRRKNGKPN PGEGDGSSEA EGGAASIQAH YKNSHLDHRH GSPMSDGNSE HSAGQSHGPP TPPTTPKTEL QAGKSDGKRD GSRSLGEGGK PHIDFGNVDI GEISHDVMAN METFDVNEFD QYLPPNGHAG HPSHIGGYTS SYGLSGALAA GPSAWALAKQ HPQTDSKAQV KTESSSTSHY TEQPSTSQLT YTSLGLPHYG SAFPSISRPQ FDYADHQPSS SYYSHSSQAS SLYSAFSYMG PPQRPLYTAI SDSPSVAQSH SPTHWEQPVY TTLSRP
Uniprot No.

Target Background

Function
Sox10 acts early in neural crest formation, working with Sox8 and Sox9 to induce neural crest progenitors. It functions downstream of Wnt signaling at the neural plate border and is involved in specifying neural crest progenitors that will form pigment cells.
Database Links
Subcellular Location
Cytoplasm. Nucleus.

Q&A

What is Sox10 and why is it important in Xenopus tropicalis research?

Sox10 is a transcription factor belonging to the SRY-related HMG-box (SOX) family of proteins that plays critical roles in neural crest development. In Xenopus tropicalis, Sox10 functions in the specification, migration, and differentiation of neural crest cells, which give rise to diverse cell types including peripheral neurons, glia, melanocytes, and craniofacial structures . Xenopus tropicalis offers significant advantages for Sox10 research due to its diploid genome (unlike the allotetraploid X. laevis) and shorter generation time, making it more amenable to genetic analysis while maintaining similar developmental patterns to X. laevis .

What is the molecular structure of Xenopus tropicalis Sox10?

Xenopus tropicalis Sox10 is a 436 amino acid protein containing an HMG-box DNA-binding domain characteristic of SOX family proteins . The full sequence includes multiple functional domains: an N-terminal region (amino acids 1-60), the DNA-binding HMG domain (approximately amino acids 101-180), and C-terminal transactivation domains. The protein contains regions involved in dimerization, partner protein interactions, and transcriptional regulation . The amino acid sequence includes specific motifs that contribute to its neural crest-specific functions, with high conservation in the HMG domain compared to Sox10 in other vertebrate species.

How does Sox10 expression pattern correlate with neural crest development in Xenopus tropicalis?

Sox10 expression in Xenopus tropicalis follows a dynamic pattern closely associated with neural crest development. Expression initiates in pre-migratory neural crest cells at neurula stages and continues in migratory neural crest populations . While Pax3 serves as a marker for pre-migratory neural crest, Sox10 expression is maintained in migratory neural crest cells, making it an excellent marker for tracking neural crest cell migration and differentiation . Sox10 expression persists in certain neural crest derivatives, particularly in the peripheral nervous system and melanocyte lineages, reflecting its continued role in terminal differentiation of these cell types.

What expression systems are optimal for producing recombinant Xenopus tropicalis Sox10 protein?

Recombinant Xenopus tropicalis Sox10 protein can be produced using several expression systems, each with distinct advantages:

Expression SystemAdvantagesLimitationsTypical PurityApplications
E. coliHigh yield, cost-effective, rapidLimited post-translational modifications>85%ELISA, protein-DNA interaction studies
YeastBetter folding, some post-translational modificationsModerate yield>90%ELISA, antibody production
BaculovirusExtensive post-translational modifications, proper foldingHigher cost, complex setup>85%Functional studies requiring authentic protein activity
Mammalian CellNative-like modifications, optimal foldingLower yield, expensive>85%Applications requiring fully functional protein

The choice depends on research needs, with yeast expression systems offering a good balance for many applications . For optimal results, including a purification tag (commonly His-tag) facilitates efficient isolation through affinity chromatography .

How can Sox10 transcription factor activity be assessed in Xenopus tropicalis systems?

Evaluating Sox10 transcription factor activity in Xenopus tropicalis can be accomplished through several complementary approaches:

  • Electrophoretic Mobility Shift Assays (EMSA): Using recombinant Sox10 protein with labeled DNA containing putative Sox10 binding sites to detect direct DNA binding activity .

  • Reporter Gene Assays: Transfecting cells with Sox10-responsive promoter-reporter constructs along with Sox10 expression vectors to quantify transcriptional activation.

  • Chromatin Immunoprecipitation (ChIP): Identifying genomic regions bound by Sox10 in vivo, using Sox10-specific antibodies to immunoprecipitate chromatin fragments.

  • Gene Expression Analysis: Comparing gene expression profiles in wild-type versus Sox10-depleted embryos using RT-qPCR or RNA-seq to identify Sox10-dependent genes.

  • Transgenic Reporter Lines: Creating Sox10-responsive fluorescent reporter transgenic lines to visualize Sox10 activity in vivo during development .

Each method provides different insights into Sox10 function, with combinations of these approaches yielding the most comprehensive understanding of Sox10-mediated transcriptional regulation.

What considerations are important when using recombinant Sox10 protein for antibody production?

When using recombinant Xenopus tropicalis Sox10 protein for antibody production, several factors must be considered:

  • Protein Quality: Ensure high purity (>90%) of recombinant Sox10 to minimize antibodies against contaminants .

  • Epitope Selection: Choose unique, surface-exposed regions of Sox10 that differ from other SOX family members to enhance specificity.

  • Cross-Reactivity Assessment: Test antibodies against related SOX proteins and in Sox10-depleted samples to confirm specificity.

  • Species Cross-Reactivity: Determine if antibodies recognize Sox10 from other Xenopus species or model organisms by aligning epitope sequences.

  • Functional Validation: Verify that antibodies detect native Sox10 in Xenopus tropicalis tissues using Western blot, immunohistochemistry, and immunoprecipitation.

  • Application Optimization: Different applications (Western blot, immunohistochemistry, ChIP) may require different antibody properties, potentially necessitating multiple antibodies targeting different epitopes.

How can transgenesis be employed to study Sox10 function in Xenopus tropicalis?

Transgenic approaches offer powerful tools for investigating Sox10 function in Xenopus tropicalis:

  • Sox10 Reporter Lines: Transgenic lines like Sox10-GFP, where GFP expression is driven by Sox10 regulatory elements, enable visualization of Sox10-expressing neural crest cells during migration in living embryos .

  • Gain-of-Function Studies: Transgenic lines overexpressing wild-type or constitutively active forms of Sox10 can reveal the consequences of elevated Sox10 activity on neural crest development.

  • Loss-of-Function Approaches: Dominant-negative Sox10 constructs expressed under tissue-specific promoters can inhibit endogenous Sox10 function in targeted cell populations.

  • CRISPR/Cas9 Genome Editing: Creating precise mutations in the Sox10 gene or regulatory regions to study specific domain functions or expression control elements.

  • Inducible Systems: Heat-shock or chemical-inducible promoters driving Sox10 variants allow temporal control over Sox10 manipulation during development.

  • Lineage Tracing: Combining Sox10 regulatory elements with Cre recombinase and reporter constructs enables fate mapping of Sox10-expressing cells throughout development.

These transgenic approaches benefit from X. tropicalis's diploid genome and are complementary to techniques like in situ hybridization and immunohistochemistry for a comprehensive analysis of Sox10 function .

What methodological approaches can distinguish between direct and indirect Sox10 target genes?

Distinguishing direct from indirect Sox10 target genes requires combinatorial approaches:

  • Integrated ChIP-seq and RNA-seq Analysis: Combining Sox10 ChIP-seq to identify genome-wide binding sites with RNA-seq after Sox10 manipulation reveals genes both bound and regulated by Sox10 .

  • Time-Course Expression Analysis: Direct targets typically show more rapid expression changes after Sox10 manipulation than indirect targets.

  • Protein Synthesis Inhibition: Comparing gene expression changes following Sox10 activation in the presence versus absence of protein synthesis inhibitors (e.g., cycloheximide) helps identify primary targets.

  • Enhancer Reporter Assays: Testing Sox10-bound genomic regions for enhancer activity in reporter assays validates functional Sox10 binding sites.

  • Motif Mutation Analysis: Targeted mutation of predicted Sox10 binding motifs in regulatory regions should abolish regulation of direct targets.

  • In Vivo Occupancy Kinetics: ChIP time-course experiments can reveal temporal dynamics of Sox10 binding correlated with target gene expression.

This multi-faceted approach provides confidence in identifying the direct transcriptional network controlled by Sox10 during neural crest development.

How can Sox10 function be studied in the context of neural crest migration in Xenopus tropicalis?

Investigating Sox10's role in neural crest migration requires specialized techniques:

  • Live Imaging of Sox10-GFP Transgenic Embryos: Sox10-GFP transgenic lines allow real-time visualization of neural crest cell migration dynamics . Time-lapse confocal or light-sheet microscopy can track individual cell behaviors, migration paths, and cell-cell interactions.

  • Tissue-Specific Sox10 Perturbation: Using neural crest-specific promoters to drive Sox10 variants (wild-type, dominant-negative, or constitutively active) specifically in migratory neural crest cells.

  • Neural Crest Explant Cultures: Isolating neural crest explants from control and Sox10-manipulated embryos to assess migration behavior in controlled in vitro environments.

  • Transplantation Experiments: Grafting labeled neural crest cells between wild-type and Sox10-manipulated embryos to distinguish cell-autonomous from non-cell-autonomous migration defects.

  • Molecular Analysis of Migration Machinery: Examining how Sox10 manipulation affects expression of cell adhesion molecules, matrix metalloproteinases, and cytoskeletal regulators involved in migration.

  • Correlation with Environmental Cues: Analyzing how Sox10 interacts with or regulates response to guidance cues that pattern neural crest migration pathways.

These approaches collectively reveal how Sox10 contributes to the complex process of neural crest cell migration in vivo .

What are common challenges in Sox10 protein expression and purification, and how can they be addressed?

Researchers encounter several challenges when expressing and purifying recombinant Xenopus tropicalis Sox10:

ChallengePossible CausesSolutions
Poor solubilityHMG domain aggregation, improper foldingUse solubility tags (MBP, SUMO), lower induction temperature (16-20°C), include solubility enhancers (0.1% Triton X-100, 10% glycerol)
Low yieldCodon bias, toxicity to host cellsOptimize codons for expression host, use tightly regulated expression systems, consider cell-free protein synthesis
Protein degradationProteolytic susceptibilityInclude protease inhibitor cocktail, perform purification at 4°C, reduce purification time
DNA contaminationHMG domain DNA bindingInclude DNase treatment, high salt washes (0.5-1M NaCl) during purification
Loss of activityImproper folding, critical residue modificationUse mild purification conditions, confirm activity with DNA-binding assays, consider eukaryotic expression systems

For optimal results with yeast expression systems, maintaining >90% protein purity is achievable by including multiple purification steps and optimizing buffer conditions .

How can specificity be ensured when detecting Sox10 expression in Xenopus tropicalis tissues?

Ensuring specific detection of Sox10 in Xenopus tropicalis tissues requires rigorous validation:

  • Antibody Validation Controls:

    • Positive control: Tissues known to express Sox10 (e.g., neural crest)

    • Negative control: Sox10-depleted tissues (morpholino injected or CRISPR mutants)

    • Peptide competition assays to confirm binding specificity

  • RNA Probe Specificity for In Situ Hybridization:

    • Design probes targeting unique regions not conserved in other Sox family members

    • Include sense probe controls

    • Validate expression patterns with multiple non-overlapping probes

  • Cross-Species Considerations:

    • When using reagents developed for X. laevis, align sequences to confirm conservation

    • For antibodies raised against mammalian Sox10, verify epitope conservation in X. tropicalis

  • Distinguishing from Related Sox Proteins:

    • Compare expression patterns with other Sox family members

    • Use double labeling to identify co-expression or mutual exclusion

  • Signal Amplification Without Increasing Background:

    • Employ tyramide signal amplification for low-abundance detection

    • Optimize blocking conditions to minimize non-specific binding

These validation steps ensure that observed signals accurately represent Sox10 expression rather than related proteins or artifacts .

What experimental design considerations minimize variability in Sox10 functional studies?

Robust experimental design is crucial for reducing variability in Sox10 functional studies:

  • Genetic Background Control:

    • Use siblings from single mating pairs

    • Maintain inbred lines to reduce genetic heterogeneity

  • Environmental Standardization:

    • Strictly control temperature (25-28°C optimal range for X. tropicalis)

    • Standardize housing density and water quality

    • Maintain consistent light/dark cycles

  • Developmental Staging:

    • Precisely stage embryos according to Nieuwkoop and Faber criteria

    • Select embryos at identical developmental points rather than by time post-fertilization

  • Internal Controls:

    • Use half-embryo injections where one side serves as an internal control

    • Include lineage tracers to confirm targeting

  • Quantitative Analysis:

    • Develop objective scoring criteria for phenotypes

    • Use automated image analysis where possible

    • Perform blinded assessment of phenotypes

  • Statistical Considerations:

    • Determine appropriate sample sizes through power analysis

    • Account for clutch-to-clutch variability in statistical models

    • Report detailed statistics including effect sizes

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.